EDIT vs MU · rev $32.3M vs P/E 21, rev $37.38B
Editas Medicine Inc (EDIT) versus Micron Technology Inc (MU) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Micron Technology Inc (MU) is a semiconductors company listed on US. It is led by Sanjay Mehrotra.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported MU revenue for 2025-08-28 was $37.38B. Net income was $8.54B. MU currently screens at market cap $187.25B and trailing P/E 20.7.
EDIT currently screens at market cap $375.2M. MU currently screens at market cap $187.25B and trailing P/E 20.7.
Not investment advice. Open the EDIT and MU stock pages for the full models.
Not investment advice.